All Pharma News
Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast

Sangamo Therapeutics Announces First Quarter 2024 Conference Call and Webcast
BUSINESSWIRE
02 May 2024
Share Share
Sangamo`s Neuro Gene Editing, Delivery Platforms At ASGCT

Sangamo`s Neuro Gene Editing, Delivery Platforms At ASGCT
BUSINESSWIRE
22 Apr 2024
Share Share
Sangamo Announces Pricing of $24.0 Million Registered Direct Offering

Sangamo Announces Pricing of $24.0 Million Registered Direct Offering
BUSINESSWIRE
22 Mar 2024
Share Share
Sangamo Announces Data From Novel Proprietary Neurotropic AAV Capsid

Sangamo Announces Data From Novel Proprietary Neurotropic AAV Capsid
BUSINESSWIRE
13 Mar 2024
Share Share
Sangamo Reports Fourth Quarter and Full Year 2023 Financial Results

Sangamo Reports Fourth Quarter and Full Year 2023 Financial Results
BUSINESSWIRE
13 Mar 2024
Share Share
Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call

Sangamo Therapeutics Announces Fourth Quarter and Full Year 2023 Conference Call
BUSINESSWIRE
12 Mar 2024
Share Share
Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease

Sangamo Therapeutics Announces U.S. FDA Alignment on Abbreviated Pathway to Potential Approval and EMA Prime Eligibility for ST-920 in Fabry Disease
BUSINESSWIRE
12 Feb 2024
Share Share
Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease

Sangamo Announces Updated Phase 1/2 STAAR Study Data in Fabry Disease
BUSINESSWIRE
05 Feb 2024
Share Share
Sangamo lays off 160+ staffers

Sangamo lays off 160+ staffers
Amber Tong ENDPTS
02 Nov 2023
Share Share
Rani and Sangamo jettison staff, assets to keep afloat next year

Rani and Sangamo jettison staff, assets to keep afloat next year
James Waldron FIERCE BIOTECH
02 Nov 2023
Share Share